Journey Medical Corporation Common Stock (DERM)
Stock · NASDAQ · Health Care
$4.96as of 10/16/2026
Price chart
Active signals
DERM Signal Track Record
How signals performed across all stocks →What DERM's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 40 | +1.7% | 57% | September 10, 2026 |
| Bollinger Band Breakout | 26 | -1.4% | 46% | August 20, 2026 |
| Bollinger Band BreakdownActive now | 15 | -1.6% | 47% | September 23, 2026 |
| 200-Day Moving Average TouchActive now | 12 | +14.1% | 75% | September 21, 2026 |
| Any 20-session window (baseline) | +1.0% | 52% |
Computed by MarketWall from daily closing prices since August 30, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About DERM
Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodu…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 58
- Website
- journeymedicalcorp.com/
Fundamentals
- 1-day range
- $4.78$5.18
- Market cap
- $179.80M
- P/E (trailing)
- —
- P/E (forward)
- -82.75
- EPS (trailing)
- $-0.23
- Dividend yield
- —
- Beta
- 1.09
- Avg. volume
- 189.7K
How Journey Medical Corporation Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 26, 2026 · via SEC EDGAR / Finnhub
Forecasts
4 analyst ratings
Journey Medical Corporation Common Stock Competitors
Chosen by industry and closest market cap.
- DERMJourney Medical Corporation Common Stock$4.97▼ 3.12%Market cap $179.80MP/E —$4.31$9.56
- CRBPCorbus Pharmaceuticals Holdings Inc. Common Stock$4.52▲ 4.39%Market cap $180.46MP/E —$4.23$20.56
- ORMPOramed Pharmaceuticals Inc. Common Stock$4.07▼ 2.63%Market cap $178.87MP/E 0.98$2.09$5.47
- LFCRLifecore Biomedical Inc. Common Stock$6.38▼ 0.93%Market cap $181.55MP/E —$3.63$8.98
- KRROKorro Bio Inc. Common Stock$8.49▼ 8.81%Market cap $174.80MP/E —$5.2$55.89
- TNXPTonix Pharmaceuticals Holding Corp. Common Stock$6.04▼ 5.92%Market cap $185.71MP/E —$6.01$20.69
- ARCTArcturus Therapeutics Holdings Inc. Common Stock$10.34▼ 8.25%Market cap $172.81MP/E —$5.5$24.17
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| DERM Journey Medical Corporation Common Stock | $179.80M | — | $4.97 | ▼ 3.12% | $4.31$9.56 |
| CRBP Corbus Pharmaceuticals Holdings Inc. Common Stock | $180.46M | — | $4.52 | ▲ 4.39% | $4.23$20.56 |
| ORMP Oramed Pharmaceuticals Inc. Common Stock | $178.87M | 0.98 | $4.07 | ▼ 2.63% | $2.09$5.47 |
| LFCR Lifecore Biomedical Inc. Common Stock | $181.55M | — | $6.38 | ▼ 0.93% | $3.63$8.98 |
| KRRO Korro Bio Inc. Common Stock | $174.80M | — | $8.49 | ▼ 8.81% | $5.2$55.89 |
| TNXP Tonix Pharmaceuticals Holding Corp. Common Stock | $185.71M | — | $6.04 | ▼ 5.92% | $6.01$20.69 |
| ARCT Arcturus Therapeutics Holdings Inc. Common Stock | $172.81M | — | $10.34 | ▼ 8.25% | $5.5$24.17 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Are Options Traders Betting on a Big Move in Journey Medical Stock?Yahoo · 9/21/2026
- Journey Medical: A Small Pharma With A Large Growth OpportunitySeekingAlpha · 9/19/2026
Insider Activity
Insider Actions →- Neil Herskowitz · July 1, 2026 · Grant50.0K
- Justin Adam Smith · July 1, 2026 · Grant50.0K
- Miranda Jayne Toledano · July 1, 2026 · Grant50.0K
- Justin Adam Smith · June 25, 2026 · Grant10.0K
- Lindsay A. Rosenwald, MD · June 25, 2026 · Grant10.0K
- Michael Cooper Pearce · June 25, 2026 · Grant10.0K
- Neil Herskowitz · June 25, 2026 · Grant10.0K
- Ramsey Alloush · April 22, 2026 · Grant62.8K
- Ramsey Alloush · April 22, 2026 · Grant46.9K
- Joseph Benesch · April 22, 2026 · Grant41.9K
- Joseph Benesch · April 22, 2026 · Grant28.9K
- Claude Maraoui · April 22, 2026 · Grant82.9K
- Claude Maraoui · April 22, 2026 · Grant49.3K
Institutional Ownership
March 31, 2026
- Total shares held
- 11.53M
- Total value held
- $54.02M
- Institutional holders
- 67
- Unknown2.13M
- Unknown1.61M
- Unknown1.08M
- Unknown972.9K
- Unknown960.0K
- Unknown500.2K
- Unknown482.0K
- Unknown463.2K
- Unknown390.1K
- Unknown383.1K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Options Activity Signals Possible Move in Journey Medical (DERM)
Options traders are increasing positions in Journey Medical, hinting at a potential price move. The stock is near its 9‑touch support level of $6.05 and has recently touched the 200‑day SMA, adding to the technical backdrop. Analysts currently target a range of $13.00 to $15.00, well above the 52‑week high of $9.55.
Options Activity Signals Possible Move in Journey Medical (DERM). Options traders are increasing positions in Journey Medical, hinting at a potential price move. The stock is near its 9‑touch support level of $6.05 and has recently touched the 200‑day SMA, adding to the technical backdrop. Analysts currently target a range of $13.00 to $15.00, well above the 52‑week high of $9.55.